Abstract
Kimura’s disease (KD) is a rare chronic inflammatory condition characterized by eosinophilic granulomas, typically in the head and neck. While generally benign, it is prone to recurrence and its systemic vascular implications are poorly understood. We report a rare case of a 58-year-old male with KD who developed a brain stem infarction due to an intracranial thrombosed aneurysm despite 20 years of steroid therapy. Imaging revealed multiple systemic aneurysms, including in the vertebral and common iliac arteries. This case suggests that patients with KD may remain at risk for systemic vascular complications even when the primary disease appears well-controlled by long-term steroids.
Introduction
Kimura’s disease (KD) is a chronic inflammatory disorder that presents as painless subcutaneous masses, primarily in the head and neck region, often associated with peripheral blood eosinophilia and elevated serum IgE levels. While the disease itself is non-malignant, its management is challenging due to high recurrence rates. Standard treatment often involves long-term corticosteroid administration. However, the systemic effects of KD and its treatment on the vasculature are not fully elucidated. This report describes a patient who suffered a stroke from a clotted aneurysm while on long-term steroid therapy for KD.
Case Presentation
A 58-year-old male presented with dysarthria and gait disturbance. He had a 20-year history of Kimura’s disease, managed with 4–10 mg/day of prednisolone. At the time of admission, his eosinophil count was significantly elevated at 32.8%.
Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) were performed immediately. Diffusion-weighted imaging (DWI) identified an acute infarction in the left pons (brain stem). Furthermore, MRA and T2-weighted imaging revealed a large, thrombosed fusiform aneurysm extending from the basilar artery to the left vertebral artery.
To assess the extent of vascular involvement, systemic imaging was conducted. 3D digital subtraction angiography (DSA) identified additional aneurysms in the extracranial right vertebral artery. Contrast-enhanced CT of the chest and abdomen further revealed a thrombosed aneurysm in the right common iliac artery.
The patient was treated conservatively with antiplatelet therapy (Aspirin) while continuing his steroid regimen. His neurological symptoms improved, and he was discharged after nine days, capable of independent ambulation.
Discussion
This case highlights a critical clinical "blind spot" in the management of Kimura’s disease. The occurrence of multiple systemic aneurysms—intracranial, extracranial vertebral, and iliac—suggests a systemic vascular vulnerability.
Two primary mechanisms may be at play. First, the "Steroid Paradox": while steroids suppress eosinophilic inflammation, long-term use (20 years in this case) is a known risk factor for atherosclerosis and vessel wall weakening. Second, the role of eosinophils: despite steroid therapy, the patient maintained high eosinophil levels. Eosinophils are known to promote a hypercoagulable state and can induce vasculitis, potentially leading to the formation and subsequent thrombosis of aneurysms.
This is the first reported instance of intracranial vascular complications occurring during long-term steroid therapy for KD. It underscores that "stable" patients may still harbor silent, life-threatening vascular lesions.
Conclusion
Clinicians should maintain a high index of suspicion for vascular complications in patients with Kimura’s disease, even those undergoing long-term steroid therapy. Periodic systemic vascular screening, such as MRA or CT angiography, may be warranted to detect aneurysms before they lead to catastrophic events like stroke.
Summary updated